US 5-11 aged children could make vaccination appointment in early Nov.
- Japan Second Round of Nuclear Contaminated Water Discharge Set to Commence
- Johns Hopkins University: Early Plasma Therapy Reduces Long COVID Risk
- Ketogenic Diet Linked to Heart Diseases and Cancers
- TROP2 ADC for Breast Cancer Succeeded In Phase III Clinical Trials
- Lead Poisoning’s More Serious Impacts on Health and IQ
- Startling Link Between Alcohol and Alzheimer’s Disease
U.S. 5-11 aged children could make vaccination appointment in early Nov. if FDA approved it on Oct. 26
- Nearly 300 People Food Poisoning in Japanese 130-Year Restaurant
- FDA’s First Potential TIL Therapy Review Delayed: How to Understand FDA’s “Resource Constraints”?
- A Chinese Doctor Accused of Accepting Bribes Totaling US$166 Million
- Nuclear contaminated water: Japanese government paid bribes and corrected the IAEA report
- Top 20 Companies of Instruments and Medical Equipment In The World
- The first DMD gene therapy SRP-9001 may cost 4 million US dollars
- How long can the patient live after heart stent surgery?
U.S. 5-11 aged children could make vaccination appointment in early Nov. if FDA approved it on Oct. 26.
At present, COVID-19 vaccines have been approved for use in people aged 12 and over in the United States, but 28 million elementary school students in the 5-11 age group are still waiting for the approval of Pfizer-BioNTech mRNA vaccine.
On October 18, 2021, the American Children’s Association (AAP) updated the status of COVID-19 infection in children in the United States. In the past week, the United States has added more than 130,000 new cases of COVID-19 in children, accounting for all new cases each week. An increase of 25.5% of cases.
As a result, by October 15, 2021, the number of COVID-19 cases among children in the United States has reached 6.17 million, accounting for 16.4% of all cases and 8.2% of all American children!
At a media conference today (October 20), the Biden administration stated that for 5-11 year-old vaccination, the vaccine has been prepared and is only awaiting approval.
According to regulations, the advisory committee of the US Food and Drug Administration (FDA) is expected to make a decision on whether Pfizer’s mRNA vaccine can be applied to children on October 26, and then the independent advisory committee of the US Centers for Disease Control and Prevention (CDC) will Review and approval from November 2nd to 3rd.
Once both FDA and CDC approve, vaccination can be implemented immediately.
In response, Jeff Zients, the White House COVID-19 response coordinator, said: We have already begun work to deploy vaccination.
For specific vaccination plans, it will be widely deployed, including pediatrician outpatient clinics, other family doctor places, more than 100 children’s hospitals, tens of thousands of pharmacies, and community clinics.
Even considering the medical staff to bring the vaccine to the school, inoculation on the school site.
The vaccine dose for children aged 5-11 years is also different from that for age groups 12 years and older. It is 10ug/dose, which is only 1/3 of the standard dose.
U.S. 5-11 aged children could make vaccination appointment in early Nov. if FDA approved on Oct. 26
(source:internet, reference only)
Disclaimer of medicaltrend.org
